Roman warfare: targeting of support cells in AML
- PMID: 30733203
- DOI: 10.1182/blood-2018-12-887497
Roman warfare: targeting of support cells in AML
Conflict of interest statement
Conflict-of-interest disclosure: C.C.S. has received research funding from Plexxikon Inc., Astellas Pharma, FujiFilm Pharmaceuticals, and Revolution Medicines.
Comment on
-
CSF1R inhibitors exhibit antitumor activity in acute myeloid leukemia by blocking paracrine signals from support cells.Blood. 2019 Feb 7;133(6):588-599. doi: 10.1182/blood-2018-03-838946. Epub 2018 Nov 13. Blood. 2019. PMID: 30425048 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical

